1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Texas >
  6. Summit Clinical Research Acquires Houston Research Institute

M&A Deal Summary

Summit Clinical Research Acquires Houston Research Institute

On May 1, 2025, Summit Clinical Research acquired life science company Houston Research Institute

Acquisition Highlights
  • This is Summit Clinical Research’s 1st transaction in the Life Science sector.
  • This is Summit Clinical Research’s 1st transaction in the United States.
  • This is Summit Clinical Research’s 1st transaction in Texas.

M&A Deal Summary
Date 2025-05-01
Target Houston Research Institute
Sector Life Science
Buyer(s) Summit Clinical Research
Deal Type Add-on Acquisition

Target

Houston Research Institute

Houston, Texas, United States
Houston Research Institute is a clinical practice and research institute. The company provide specialized diagnostics, evaluation, treatment and clinical trial options for patients with fatty liver disease , other liver conditions, CVD and Obesity. Houston Research Institute is based in Houston, Texas.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Summit Clinical Research

San Antonio, Texas, United States
Category Company
Founded 2018
Sector Life Science
DESCRIPTION

Summit Clinical Research is an integrated research organization (“IRO”) specializing in complex indications, including hepatology with a focus on non-alcoholic fatty liver disease (“NAFLD”) and nonalcoholic steatohepatitis (“NASH”). Summit Clinical Research was founded in 2018 and is based in San Antonio, Texas.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal